Unlock instant, AI-driven research and patent intelligence for your innovation.
Preparation technique of protein microsphere suppository
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A production process, protein technology, applied in drug delivery, non-active ingredients of polymer compounds, non-active ingredients of oil/fat/wax, etc., can solve problems such as inflammatory response and toxicity
Inactive Publication Date: 2008-12-31
WUHAN INSTITUTE OF TECHNOLOGY
View PDF0 Cites 13 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, common cross-linking agents (such as glutaraldehyde, formaldehyde, etc.) have certain toxicity, and the residual cross-linking agent in the microsphere embolism prepared by the method of curing with these cross-linking agents is easy to cause the inflammatory response of the human body
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0011] Example 1: Preparation of gelatin microspheres
[0012] Raw materials and sources
[0013] Gelatin [China National Pharmaceutical Group Shanghai Chemical Reagent Company]
[0017] 20ml of gelatinaqueous solution (20%, mass ratio) was added to 100ml of soybean oil for emulsification at a temperature of 50°C, then cooled, washed with acetone to remove the oil, centrifuged, and dried to obtain protein microspheres. Add the dried protein microspheres to soybean oil preheated to 100°C, keep it at this temperature for 24 hours, wash off the oil with acetone, dry, sieving and grading, and then bottling and capping.
Embodiment 2
[0018] Example 2: Preparation of Gelatin Microspheres
[0019] Raw materials and sources
[0020] Gelatin [China National Pharmaceutical Group Shanghai Chemical Reagent Company]
[0024] 40ml of gelatin aqueous solution (30%, mass ratio) was added to 100ml of soybean oil for emulsification at a temperature of 60°C, then cooled, washed with acetone to remove the oil, centrifuged, and dried to obtain protein microspheres. Place the dried protein microspheres in an oven preheated to 150°C, keep this temperature for 24 hours, cool, sieving and grading, and then bottling and capping.
Embodiment 3
[0025] Example 3: Preparation of albumin microspheres
[0026] Raw materials and sources
[0027] Albumin 【Wuhan Institute of Biological Products】
[0031] 20ml of bovine serum albumin aqueous solution (33%, mass ratio) was added to 100ml of peanut oil for emulsification at a temperature of 50°C, then cooled, washed with acetone to remove the oil, centrifuged, and dried to obtain protein microspheres. Place the dried protein microspheres in a watch glass, then place the watch glass in a sand bath, heat it to 150°C, keep it at this temperature for 24 hours, cool, sieving and grading, and then bottling and capping.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention relates to a manufacture technology of an embolic agent, in particular to a manufacture technology of a proteinmicrosphereembolic agent. The manufacture technology is realized by the following steps: proteinaqueous solution is added into vegetable oil for emulsification under the temperature of 40 DEG C to 70 DEG C; protein microspheres are obtained after deoiling and drying, wherein, the volume ratio of the protein aqueous solution and the vegetable oil is 1 to 2:5; then, the obtained protein microspheres are subject to thermal crosslinking to be solidified; the protein microspheres obtained after solidification are sieved and graded or are deoiled, dried, sieved and graded to obtain a microsphereembolic agent in different particle diameters. An emulsification method is used, so the manufactured protein microspheres have regular shapes; the protein microspheres which are heated and solidified can take effect of the protein microspheres which are solidified by a cross linker and do not contain residual cross linker, and the protein microsphere embolic agent is safer to human body and is fit for the interventional therapy better.
Description
Technical field [0001] The invention relates to a manufacturing process of an embolic agent, in particular to a manufacturing process of a protein microsphere embolic agent. Background technique [0002] At present, interventional therapy has been widely used in the treatment of a variety of tumor diseases. Interventional therapy refers to inserting catheters and instruments made of special materials into the tumor site in the body under the guidance of X-rays, and then injecting anti-tumor drugs through the blood supplyartery or blocking the blood supply of tumor tissue, so that the tumor necrosis and Atrophy, achieve the purpose of treatment. The use of particulate embolic agents that block the blood supply of tumor tissue is an important means of interventional therapy. Protein particles are one of the most common vascular embolization materials in clinical practice. During their preparation, cross-linking agents are usually used to solidify the protein. However, common cross...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.